Prophylactic Antibiotic Coated Nail to Prevent Infection

This study is comparing two ways to prevent infection after severe leg fractures (open tibia fractures). You might be eligible if you are 18 or older and need surgery for a Gustilo Type II or III open tibia fracture. The study is testing an antibiotic-coated intramedullary nail (a rod placed inside the bone) containing vancomycin and gentamicin, against a standard intramedullary nail. The main goal is to see how many participants develop a deep surgical site infection (SSI) within 12 months. This research aims to find better ways to reduce infections, which are a major problem for people with these types of injuries. The study plans to enroll 484 participants, but its current status is unclear.

Study design
This is a randomized clinical trial, meaning participants will be randomly assigned to receive either the antibiotic-coated nail or the standard nail. The study plans to enroll 484 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for deep surgical site infection for up to 12 months after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05421741

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Recruiting
PHASE4Ages 18+InterventionalPrevention
Wake Forest University Health Sciences
~242 participants
Updated 2026-08-18 on ClinicalTrials.gov
What's tested:Antibiotic coated intramedullary NailStandard Intramedullary Nail

At a glance

Recruiting sites
14 of 15 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of Participants who develop deep surgical site infection (SSI)
Measured over Day 30 through month 12
Osteomyelitis Tibia
Tibial Fractures
Open Tibia Fracture
15 sites across 9 states
North Carolina4
Florida2
Texas2
Virginia2
Georgia1
Illinois1
Kentucky1
Pennsylvania1
  • Joseph Hsu, MD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients 18 years or older
Gustilo Type II or III open tibia fracture requiring definitive fixation with intramedullary nail

Exclusion

Less than 18 years of age
Allergy to vancomycin or gentamicin
Unable to speak English or Spanish
Pregnant and lactating women
Prisoner
Unable to follow up for 12 months
  • Number of Participants who develop deep surgical site infection (SSI)Day 30 through month 12

    Number of participants in each group who develop SSI as defined by the criteria establish by the Centers for Disease Control and Prevention (CDC). The CDC criteria define deep as occurring within 30 or 90 days after the procedure. However, we will continue to follow patients for 12 months and document any infections and other complications during this period.